Epithalamin: side effects and evidence limits
The Epithalamin listing names a pineal polypeptide complex supplied as lyophilized powder [1]. This mixture must remain distinct from synthetic Epitalon/AEDG: the inspected analytical sections identify AEDG as only one constituent of the studied complex [2].
The inspected methods and results passage of a 2006 paper concern a historical epithalamin preparation in older coronary patients. Intramuscular courses spanned three years, with 12 years of observation. The authors gave a positive qualitative tolerability assessment [3].
That assessment is not an established incidence of causally attributed adverse reactions. Selected sections of the scanned paper were read, rather than a complete harms audit. Follow-up duration is not treatment duration; equivalence of the historical preparation and current powder remains unverified. These data do not establish clinical safety of the current product [1–3].
What the studies reported
| Effect | Model or participants | How often or as described | Source |
|---|---|---|---|
| Tolerability of the historical epithalamin preparation | Older patients with coronary disease, intramuscular courses over three years, 12 years of observation | The authors gave a positive qualitative tolerability assessment; there is no established incidence of causally attributed adverse reactions, and no complete harms audit was performed | [3] |
| Applicability of the historical data to the current product | Pineal polypeptide complex (a mixture); AEDG is only one of its constituents | Equivalence of the historical preparation and the current powder remains unverified; these data do not establish clinical safety of the current product | [1][2] |
References
- Longeva (2026). Epithalamin product identity https://longeva.bio/en/product/epithalamin.
- Khavinson VK et al. (2017). Identification of Peptide AEDG in the Polypeptide Complex of the Pineal Gland https://link.springer.com/article/10.1007/s10517-017-3922-8 doi:10.1007/s10517-017-3922-8.
- Korkushko OV et al. (2006). Geroprotective effect of epithalamine (pineal gland peptide preparation) in elderly subjects with accelerated aging https://link.springer.com/article/10.1007/s10517-006-0365-z doi:10.1007/s10517-006-0365-z.